Research and Development Bibliography
Papers & Abstracts
Dittrich MT, Epperly WC, Kopelen H, Strachan GM, Harden M, Sandelski J, Malhrous H, Belcik T., JDMS September/October 2008 24:286-298: Evaluation and Optimization of Real-time Perfusion Imaging Using Multiple Ultrasound Systems with Imagify Microspheres
Senior, R et al. European Journal of Echocardiography, January 2009: Detection of Coronary Artery Disease with Perfusion Stress Echocardiography Using a Novel Ultrasound Imaging Agent: Two Phase 3 International Trials in Comparison with Radionuclide Perfusion Imaging
Pano, A et al. European Journal of Echocardiography Abstracts Supplement, December 2007. Abstract 716: Evaluation of ECG-related safety of perflubutane polymer microspheres (PPM) injectable suspension is chronic stable angina patients undergoing stress echocardiography in RAMP-1 and -2 trials.
Senior, R et al. Circulation, Annual Meeting of the American Heart Association, November 2007. Abstract 2479: Accurate Detection of Coronary Artery Disease by Echocardiography using Perflubutane Polymer Microspheres, a Novel Contrast Agent: Comparison with Nuclear Perfusion Imaging in Two Phase Three Multicenter Clinical Trials.
Mita, AC et al. Clinical Cancer Research, June 2007. Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug delivery system for paclitaxel.
Jain RA, et al. Annual Meeting and Exposition of the Controlled Release Society, 587, 2007. Preparation of an Emulsion Formulation of Clopidogrel for Intravenous Administration.
Jain RA, et al.The AAPS Journal. 2006; 8(s2) Abstract T3104. Comparison of Powder Processing Techniques for Developing an Orally Disintegrating Formulation of a Poorly Water-Soluble Drug
Jain RA, et al. Annual Meeting and Exposition of the Controlled Release Society, 991, 2006 Characterization of dry powder formulations of a poorly water-soluble drug for parenteral administration.
Straub JA, et al. Pharmaceutical Research, Vol. 22, No. 3, March 2005. Intravenous Hydrophobic Drug Delivery: A Porous Particle Formulation of Paclitaxel (AI-850)
Lewis LD, et al. J Clinical Oncology 2004 ASCO Annual Meeting Proceedings (Post Meeting Edition). Phase 1 and Pharmacokinetic Study of AI-850, a Novel Microparticle Hydrophobic Drug Delivery Systems (HDDS) for Paclitaxel
Articles
Bernstein H. Scripps Target, T&F Informa, UK Ltd. 2005. Acusphere: making speciality pharmaceuticals using porous microparticle technology.